# Phase 2 Randomized Study to Compare Ultrasonic Drug Delivery to Standard of Care for the Treatment of Infections in Non-Healing Wounds

> **NCT03732365** · PHASE2 · UNKNOWN · sponsor: **Sonescence, Inc.** · enrollment: 30 (estimated)

## Conditions studied

- Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
- Non-healing Wound

## Interventions

- **COMBINATION_PRODUCT:** Ultrasonic Drug Delivery
- **DRUG:** Standard of Care Antibiotic Treatment

## Key facts

- **NCT ID:** NCT03732365
- **Lead sponsor:** Sonescence, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-01
- **Primary completion:** 2020-01-31
- **Final completion:** 2020-07-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2018-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03732365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03732365, "Phase 2 Randomized Study to Compare Ultrasonic Drug Delivery to Standard of Care for the Treatment of Infections in Non-Healing Wounds". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT03732365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*